Found 126 clinical trials
18F-DCFPyL Positron Emission Tomography (PET) in Intermediate or High Risk Prostate Cancer
increasing prostate-specific antigen (PSA) levels.
- 0 views
- 31 May, 2021
- 1 location
Personalized Radiotherapy for Biochemical Recurrence of Prostate Cancer After Prostatectomy.
A randomized phase III trial to study the effect of adding lymph node irradiation in patients with poor prostate-specific antigen (PSA) response during salvage radiotherapy for biochemical
- 0 views
- 09 May, 2021
- 3 locations
A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery (STEEL)
Patients with post-prostatectomy PSA (Prostate Specific Antigen) recurrences with aggressive disease features will receive salvage radiation therapy and standard androgen deprivation therapy
- 150 views
- 13 Mar, 2022
- 111 locations
Diagnosing Clinically Significant Prostate Cancer In African American and White Men With Elevated PSA
with elevated prostate specific antigen. Systematic random biopsy and MRI-US fusion biopsy may work better in improving the accuracy of prostate cancer detection.
- 317 views
- 04 Oct, 2022
- 7 locations
Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA
Darolutamide is a drug that has a proven survival benefit in non-metastatic (M0) castrate resistant prostate cancer when using conventional imaging. However, it is estimated that >90% of patients have disease apparent when using PSMA PET. This study investigates the use of local consolidation radiotherapy in this cohort of men.
- 0 views
- 08 Sep, 2021
- 1 location
68Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate Cancer (PSMA)
cancer, as well as prostate cancer that may have come back in patients with elevated PSA ( a prostate-specific antigen tumor marker) after initial treatment.
- 246 views
- 24 Jan, 2022
- 1 location
The Study of Olaparib in Newly Diagnosed mCRPC Patients With HRR Gene Mutation (PROspect)
treatment and follow-up periods, all subjects will have regular visits to assess the efficacy and safety of Olaparib. Data on objective radiographic response (ORR), prostate-specific antigen response (PSA
- 0 views
- 11 Mar, 2022
- 1 location
White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA
This phase II trial studies how well white button mushroom supplement works in reducing prostate-specific antigen (PSA) levels in patients with prostate cancer that has come back (recurrent) or
- 2 views
- 04 Oct, 2022
- 5 locations
Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy (EXCALIBUR)
specific antigen (PSA) after radical prostatectomy. Stereotactic body radiation therapy uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may
- 0 views
- 04 Oct, 2022
- 1 location
Identification of Predictive Biomarkers (BioPoP)
detect lesions already at very low prostate-specific antigen (PSA) levels. The improved detection of relapses increases the interest of individualized targeted therapies in patients with prostate cancer
- 1 views
- 26 May, 2022
- 1 location